Skip to main content
SpringerLink
Log in

Detection and Diagnosis of Breast Cancer

  • Chapter
  • First Online:
A Practical Guide to Breast Cancer Treatment

  • 421 Accesses

Abstract

This chapter is about the detection and diagnosis of breast cancer, serving as an introduction to help understand the breast cancer cases to be presented in the future. Breast cancer is the most common cancer among women worldwide, accounting for a significant proportion of cancer deaths among women in their 20s to 50s. This chapter begins with a brief introduction to the anatomy of a normal breast and the necessary processes for diagnosing breast cancer, such as medical history taking, symptom and physical examination, and according to this, breast imaging tests (mammography, breast ultrasound, breast MRI, etc.) and pathological tissue examination. It also explains how to interpret the results.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 139.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 179.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • National Central Cancer Registry Statistics Report 2019. Republic of Korea.

    Google Scholar 

  • Parks AG. The micro-anatomy of the breast. Ann R Coll Surg Engl. 1959;25:235–51.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Spratt JS. Anatomy of the breast. Major Probl Clin Surg. 1979;5:1–13.

    CAS  PubMed  Google Scholar 

  • Moffat DF, Going JJ. Three dimensional anatomy of complete duct systems in human breast: pathological and developmental implications. J Clin Pathol. 1996;49(1):48–52. https://doi.org/10.1136/jcp.49.1.48.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Nathanson SD, Wachna DL, Gilman D, Karvelis K, Havstad S, Ferrara J. Pathways of lymphatic drainage from the breast. Ann Surg Oncol. 2001;8(10):837–43. https://doi.org/10.1007/s10434-001-0837-3.

  • Turner-Warwick RT. The lymphatics of the breast. Br J Surg. 1959;46:574–82. https://doi.org/10.1002/bjs.18004620004.

    Article  CAS  PubMed  Google Scholar 

  • Egan RL, McSweeney MB. Intramammary lymph nodes. Cancer. 1983;51(10):1838–42. https://doi.org/10.1002/1097-0142(19830515)51:10<1838::aid-cncr2820511014>3.0.co;2-8.

    Article  CAS  PubMed  Google Scholar 

  • Berg JW. The significance of axillary node levels in the study of breast carcinoma. Cancer. 1955;8(4):776–8. https://doi.org/10.1002/1097-0142(1955)8:4<776::aid-cncr2820080421>3.0.co;2-b.

    Article  CAS  PubMed  Google Scholar 

  • Paganelli G, Galimberti V, Trifiro G, Travaini L, De Cicco C, Mazzarol G, et al. Internal mammary node lymphoscintigraphy and biopsy in breast cancer. Q J Nucl Med. 2002;46(2):138–44.

    Google Scholar 

  • O’Malley MS, Fletcher SW. US preventive services task force. Screening for breast cancer with breast self-examination. A critical review. JAMA. 1987;257(16):2196–203.

    Google Scholar 

  • Holland R, Hendriks JH. Microcalcifications associated with ductal carcinoma in situ: mammographic-pathologic correlation. Semin Diagn Pathol. 1994;11(3):181–92.

    CAS  PubMed  Google Scholar 

  • Feig SA. Ductal carcinoma in situ. Implications for screening mammography. Radiol Clin N Am. 2000;38(4):653–68, vii. https://doi.org/10.1016/s0033-8389(05)70192-5.

  • Ikeda DM, Andersson I. Ductal carcinoma in situ: atypical mammographic appearances. Radiology. 1989;172(3):661–6. https://doi.org/10.1148/radiology.172.3.2549563.

  • Stomper PC, Connolly JL, Meyer JE, Harris JR. Clinically occult ductal carcinoma in situ detected with mammography: analysis of 100 cases with radiologic-pathologic correlation. Radiology. 1989;172(1):235–41. https://doi.org/10.1148/radiology.172.1.2544922.

  • Dershaw DD, Abramson A, Kinne DW. Ductal carcinoma in situ: mammographic findings and clinical implications. Radiology. 1989;170(2):411–5. https://doi.org/10.1148/radiology.170.2.2536185.

  • Moon WK, Im JG, Noh DY, Han MC. Nonpalpable breast lesions: evaluation with power Doppler US and a microbubble contrast agent-initial experience. Radiology. 2000;217(1):240–6. https://doi.org/10.1148/radiology.217.1.r00oc03240.

  • Buchberger W, DeKoekkoek-Doll P, Springer P, Obrist P, Dunser M. Incidental findings on sonography of the breast: clinical significance and diagnostic workup. AJR Am J Roentgenol. 1999;173(4):921–7. https://doi.org/10.2214/ajr.173.4.10511149.

  • Moon WK, Myung JS, Lee YJ, Park IA, Noh DY, Im JG. US of ductal carcinoma in situ. Radiographics. 2002;22(2):269–80; discussion 80–1. https://doi.org/10.1148/radiographics.22.2.g02mr16269.

  • Cho N, Moon WK, Cha JH, Kim SM, Kim SJ, Lee SH, et al. Sonographically guided core biopsy of the breast: comparison of 14-gauge automated gun and 11-gauge directional vacuum-assisted biopsy methods. Korean J Radiol. 2005;6(2):102–9. https://doi.org/10.3348/kjr.2005.6.2.102.

  • Berg WA, Gutierrez L, NessAiver MS, Carter WB, Bhargavan M, Lewis RS, et al. Diagnostic accuracy of mammography, clinical examination, US, and MR imaging in preoperative assessment of breast cancer. Radiology. 2004;233(3):830–49. https://doi.org/10.1148/radiol.2333031484.

  • Dronkers DJ. Stereotaxic core biopsy of breast lesions. Radiology. 1992;183(3):631–4. https://doi.org/10.1148/radiology.183.3.1584909.

  • Leconte I, Feger C, Galant C, Berliere M, Berg BV, D’Hoore W, et al. Mammography and subsequent whole-breast sonography of nonpalpable breast cancers: the importance of radiologic breast density. AJR Am J Roentgenol. 2003;180(6):1675–9. https://doi.org/10.2214/ajr.180.6.1801675.

  • Monzawa S, Yokokawa M, Sakuma T, Takao S, Hirokaga K, Hanioka K, et al. Mucinous carcinoma of the breast: MRI features of pure and mixed forms with histopathologic correlation. AJR Am J Roentgenol. 2009;192(3):W125–31. https://doi.org/10.2214/AJR.07.4021.

  • Kuhl CK, Mielcareck P, Klaschik S, Leutner C, Wardelmann E, Gieseke J, et al. Dynamic breast MR imaging: are signal intensity time course data useful for differential diagnosis of enhancing lesions? Radiology. 1999;211(1):101–10. https://doi.org/10.1148/radiology.211.1.r99ap38101.

  • Kuhl CK, Klaschik S, Mielcarek P, Gieseke J, Wardelmann E, Schild HH. Do T2-weighted pulse sequences help with the differential diagnosis of enhancing lesions in dynamic breast MRI? J Magn Reson Imaging. 1999;9(2):187–96. https://doi.org/10.1002/(sici)1522-2586(199902)9:2<187::aid-jmri6>3.0.co;2-2.

  • Orel SG, Schnall MD. MR imaging of the breast for the detection, diagnosis, and staging of breast cancer. Radiology. 2001;220(1):13–30. https://doi.org/10.1148/radiology.220.1.r01jl3113.

  • Silverstein MJ, Parker R, Grotting JC, Cote RJ, Russell CA. Ductal carcinoma in situ (DCIS) of the breast: diagnostic and therapeutic controversies. J Am Coll Surg. 2001;192(2):196–214. https://doi.org/10.1016/s1072-7515(00)00791-2.

  • Silverstein MJ, Poller DN, Waisman JR, Colburn WJ, Barth A, Gierson ED, et al. Prognostic classification of breast ductal carcinoma-in-situ. Lancet. 1995;345(8958):1154–7. https://doi.org/10.1016/s0140-6736(95)90982-6.

  • Fisher ER, Fisher B. Lobular carcinoma of the breast: an overview. Ann Surg. 1977;185(4):377–85. https://doi.org/10.1097/00000658-197704000-00001.

  • Pal SK, Lau SK, Kruper L, Nwoye U, Garberoglio C, Gupta RK, et al. Papillary carcinoma of the breast: an overview. Breast Cancer Res Treat. 2010;122(3):637–45. https://doi.org/10.1007/s10549-010-0961-5.

  • Adrada B, Arribas E, Gilcrease M, Yang WT. Invasive micropapillary carcinoma of the breast: mammographic, sonographic, and MRI features. AJR Am J Roentgenol. 2009;193(1):W58–63. https://doi.org/10.2214/AJR.08.1537.

  • Gunhan-Bilgen I, Memis A, Ustun EE, Zekioglu O, Ozdemir N. Metaplastic carcinoma of the breast: clinical, mammographic, and sonographic findings with histopathologic correlation. AJR Am J Roentgenol. 2002;178(6):1421–5. https://doi.org/10.2214/ajr.178.6.1781421.

  • Robertson FM, Bondy M, Yang W, Yamauchi H, Wiggins S, Kamrudin S, et al. Inflammatory breast cancer: the disease, the biology, the treatment. CA Cancer J Clin. 2010;60(6):351–75. https://doi.org/10.3322/caac.20082.

  • Elston CW, Ellis IO. Pathological prognostic factors in breast cancer. I. the value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology. 1991;19(5):403–10. https://doi.org/10.1111/j.1365-2559.1991.tb00229.x.

  • Rosen PP. The pathological classification of human mammary carcinoma: past, present and future. Ann Clin Lab Sci. 1979;9(2):144–56.

    Google Scholar 

  • American Joint Committee on Cancer (AJCC) 8th TNM staging system.

    Google Scholar 

  • Allred DC, Carlson RW, Berry DA, Burstein HJ, Edge SB, Goldstein LJ, et al. NCCN task force report: estrogen receptor and progesterone receptor testing in breast cancer by immunohistochemistry. J Natl Compr Cancer Netw. 2009;7(Suppl 6):S1–21; quiz S2–3. https://doi.org/10.6004/jnccn.2009.0079.

  • Allred DC, Anderson SJ, Paik S, Wickerham DL, Nagtegaal ID, Swain SM, et al. Adjuvant tamoxifen reduces subsequent breast cancer in women with estrogen receptor-positive ductal carcinoma in situ: a study based on NSABP protocol B-24. J Clin Oncol. 2012;30(12):1268–73. https://doi.org/10.1200/JCO.2010.34.0141.

  • Hammond ME, Hayes DF, Wolff AC, Mangu PB, Temin S. American Society of Clinical Oncology/College of American pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. J Oncol Pract. 2010;6(4):195–7. https://doi.org/10.1200/JOP.777003.

  • Hammond ME, Hayes DF, Dowsett M, Allred DC, Hagerty KL, Badve S, et al. American Society of Clinical Oncology/College of American pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. J Clin Oncol. 2010;28(16):2784–95. https://doi.org/10.1200/JCO.2009.25.6529.

  • Hammond ME, Hayes DF, Dowsett M, Allred DC, Hagerty KL, Badve S, et al. American Society of Clinical Oncology/College of American pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. Arch Pathol Lab Med. 2010;134(6):907–22. https://doi.org/10.1043/1543-2165-134.6.907.

  • Harvey JM, Clark GM, Osborne CK, Allred DC. Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer. J Clin Oncol. 1999;17(5):1474–81. https://doi.org/10.1200/JCO.1999.17.5.1474.

  • Bae YK, Gong G, Kang J, Lee A, Cho EY, Lee JS, et al. HER2 status by standardized immunohistochemistry and silver-enhanced in situ hybridization in Korean breast cancer. J Breast Cancer. 2012;15(4):381–7. https://doi.org/10.4048/jbc.2012.15.4.381.

  • Bae YK, Gong G, Kang J, Lee A, Cho EY, Lee JS, et al. Hormone receptor expression in invasive breast cancer among Korean women and comparison of 3 antiestrogen receptor antibodies: a multi-institutional retrospective study using tissue microarrays. Am J Surg Pathol. 2012;36(12):1817–25. https://doi.org/10.1097/PAS.0b013e318267b012.

  • Wolff AC, Hammond ME, Hicks DG, Dowsett M, McShane LM, Allison KH, et al. Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update. J Clin Oncol. 2013;31(31):3997–4013. https://doi.org/10.1200/JCO.2013.50.9984.

  • Gudlaugsson E, Skaland I, Janssen EA, Smaaland R, Shao Z, Malpica A, et al. Comparison of the effect of different techniques for measurement of Ki67 proliferation on reproducibility and prognosis prediction accuracy in breast cancer. Histopathology. 2012;61(6):1134–44. https://doi.org/10.1111/j.1365-2559.2012.04329.x.

  • Nielsen TO, Andrews HN, Cheang M, Kucab JE, Hsu FD, Ragaz J, et al. Expression of the insulin-like growth factor I receptor and urokinase plasminogen activator in breast cancer is associated with poor survival: potential for intervention with 17-allylamino geldanamycin. Cancer Res. 2004;64(1):286–91. https://doi.org/10.1158/0008-5472.can-03-1242.

  • Nielsen TO, Hsu FD, Jensen K, Cheang M, Karaca G, Hu Z, et al. Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma. Clin Cancer Res. 2004;10(16):5367–74. https://doi.org/10.1158/1078-0432.CCR-04-0220.

Download references

Author information

Authors and Affiliations

  1. Division of Breast and Endocrine, Department of General Surgery, Korea University Medical Center, Seoul, Republic of Korea

    Ji Young You

  2. Department of Surgery, Wonkwang University Sanbon Hospital, Gunpo, Gyeonggi-do, Republic of Korea

    Soojin Park

  3. Division of Surgery, Center for Breast Cancer, National Cancer Center, Goyang, Republic of Korea

    Eun-Gyeong Lee

  4. Center for Breast Cancer, National Cancer Center, Goyang, Kyonggi-do, Republic of Korea

    Eun Sook Lee

Authors
  1. Ji Young You
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Soojin Park
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Eun-Gyeong Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Eun Sook Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ji Young You .

Editor information

Editors and Affiliations

  1. Center for Breast Cancer, National Cancer Center, Goyang, Kyonggi-do, Korea (Republic of)

    Eun Sook Lee

Rights and permissions

Reprints and permissions

Copyright information

© 2023 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

You, J.Y., Park, S., Lee, EG., Lee, E.S. (2023). Detection and Diagnosis of Breast Cancer. In: Lee, E.S. (eds) A Practical Guide to Breast Cancer Treatment. Springer, Singapore. https://doi.org/10.1007/978-981-19-9044-1_1

Download citation

  • DOI: https://doi.org/10.1007/978-981-19-9044-1_1

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-19-9043-4

  • Online ISBN: 978-981-19-9044-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation